Zobrazeno 1 - 10
of 2 231
pro vyhledávání: '"Sonnenblick, A."'
Autor:
Heba Alkhatib, Jason Conage-Pough, Sangita Roy Chowdhury, Denen Shian, Deema Zaid, Ariel M. Rubinstein, Amir Sonnenblick, Tamar Peretz-Yablonsky, Avital Granit, Einat Carmon, Ishwar N. Kohale, Judy C. Boughey, Matthew P. Goetz, Liewei Wang, Forest M. White, Nataly Kravchenko-Balasha
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-7 (2024)
Abstract Triple negative breast cancer (TNBC) is a heterogeneous group of tumors which lack estrogen receptor, progesterone receptor, and HER2 expression. Targeted therapies have limited success in treating TNBC, thus a strategy enabling effective ta
Externí odkaz:
https://doaj.org/article/6e9c5a225b574c2e9c271b3e30c7bf17
Autor:
Yael Bar, Kfir Bar, Didi Feldman, Judith Ben- Dror, Meishar Shahoha, Shir Lerner, Shlomit Strulov Shachar, Ahuva Weiss-Meilik, Nachum Dershowitz, Ido Wolf, Amir Sonnenblick
Publikováno v:
Breast, Vol 77, Iss , Pp 103777- (2024)
Background: Early invasive ductal carcinoma (IDC) breast cancer often presents with a coexisting ductal carcinoma in situ (DCIS) component, while about 5 % of cases present with an extensive (>25 %) intraductal component (EIC). The impact of EIC on t
Externí odkaz:
https://doaj.org/article/4708491332944d729adf829736ab37a3
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Up to 40% of luminal breast cancer patients carry activating mutations in the PIK3CA gene. PIK3CA mutations commonly co-occur with other mutations, but the implication of this co-occurrence may vary according to the specific genes involved.
Externí odkaz:
https://doaj.org/article/ac3e0047997349598d0a0e5f200c4c04
Autor:
Didi Feldman, Liat Anabel Sinberger, Mali Salmon-Divon, Judith Ben-Dror, Shlomit Strulov Shachar, Amir Sonnenblick
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Purpose One-half of hormone receptor-positive (HR +) breast cancer (BC) patients have low expression of HER2 (HER2-low) and may benefit from trastuzumab deruxtecan (TDXd). This study aimed to identify parameters associated with HER2-low leve
Externí odkaz:
https://doaj.org/article/f1bcb80c6dcd410c82b259087f834674
Autor:
Shlomit S. Shachar, Michelle Leviov, Rinat Yerushalmi, Karen Drumea, Margarita Tokar, Lior Soussan-Gutman, Avital Bareket-Samish, Amir Sonnenblick, Noa Ben-Baruch, Ella Evron, Einav Nili Gal-Yam, Shani Paluch-Shimon, Gil Bar-Sela, Hadar Goldvaser, Salomon M. Stemmer
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-7 (2023)
Abstract Data on using the 21-gene Recurrence Score (RS) testing on second breast cancer (BC; second primary or local recurrence) are lacking. This cohort study examined patients with first and second BC, who underwent 21-gene testing both times. It
Externí odkaz:
https://doaj.org/article/3bcf6bdee0c84eafb59930d692223e0a
Autor:
Bar, Yael, Bar, Kfir, Feldman, Didi, Dror, Judith Ben, Shahoha, Meishar, Lerner, Shir, Shachar, Shlomit Strulov, Weiss-Meilik, Ahuva, Dershowitz, Nachum, Wolf, Ido, Sonnenblick, Amir
Publikováno v:
In The Breast October 2024 77
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Impressive advances have been seen in cancer immunotherapy during the last years. Although breast cancer (BC) has been long considered as non-immunogenic, immunotherapy for the treatment of BC is now emerging as a new promising therapeutic approach w
Externí odkaz:
https://doaj.org/article/d9aa799809d14c5799ec51422f807e9b
Autor:
Ofer Rotem, Idit Peretz, Michelle Leviov, Iryna Kuchuk, Amit Itay, Margarita Tokar, Shani Paluch-Shimon, Ofra Maimon, Rinat Yerushalmi, Karen Drumea, Ella Evron, Amir Sonnenblick, Einav Gal-Yam, Hadar Goldvaser, Yosef Samih, Rotem Merose, Avital Bareket-Samish, Lior Soussan-Gutman, Salomon M. Stemmer
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Data on adjuvant chemotherapy (CT) benefit in ER + HER2‒ early-stage breast cancer (EBC) patients with Recurrence Score (RS) 26-30 are limited. This real-world study evaluated the relationships between the RS, adjuvant treatments, and outc
Externí odkaz:
https://doaj.org/article/ee418dc5761c458bb5099fc02f2cafa0
Autor:
Shay Golan, Vered Bar, Seth J. Salpeter, Guy Neev, German Creiderman, Daniel Kedar, Sara Aharon, Lubov Turovsky, Adi Zundelevich, Hamutal Shahar, Hagit Shapira, Giuseppe Mallel, Erez Stossel, Nancy Gavert, Ravid Straussman, Zohar Dotan, Raanan Berger, Chani Stossel, Talia Golan, Sharon Halperin, Dan Leibovici, Shani Breuer, Yakir Rottenberg, Liat Applebaum, Ayala Hubert, Hovav Nechushtan, Tamar Peretz, Aviad Zick, Boris Chertin, Dmitry Koulikov, Amir Sonnenblick, Eli Rosenbaum
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionEx vivo organ cultures (EVOC) were recently optimized to sustain cancer tissue for 5 days with its complete microenvironment. We examined the ability of an EVOC platform to predict patient response to cancer therapy.MethodsA multicenter,
Externí odkaz:
https://doaj.org/article/9e606d0806d6437093649828fdd409d0
Autor:
Anderson, Emma, McCurley, Jessica L., Sonnenblick, Ross, McGovern, Sydney, Fung, Vicki, Levy, Douglas E., Clark, Cheryl R., Thorndike, Anne N.
Publikováno v:
In Journal of the Academy of Nutrition and Dietetics October 2023 123(10):1470-1478